HOME >> MEDICINE >> NEWS
Hepatitis B patients' understanding of infection and treatment deficient

Many patients with chronic hepatitis B are deficient in their understanding of the lifelong disease and often do not comply with the drug regimens necessary to control it, according to a new UCLA survey that suggests improved patient involvement in disease management decisions could be the key to fixing this problem.

The national survey funded by Idenix Pharmaceuticals and Novartis Pharma AG and presented May 20 during the annual Digestive Diseases Week conference in Washington, D.C. indicates that patient involvement in disease management decisions need to be improved, which could result in better adherence to drug regimens and improved clinical outcomes.

The results of this study are very compelling and are a wake-up call to physicians caring for hepatitis B patients that we need to educate our patients more about risk factors, modes of transmission and expectations regarding antiviral therapy, said Dr. Steven-Huy Han, associate clinical professor of medicine and surgery in the division of digestive diseases at the David Geffen School of Medicine at UCLA and a consultant for both Idenix and Novartis.

The study was based on responses from 301 adult chronic hepatitis B patients on antiviral therapy. Of those, 24 percent were on interferon treatment. Most of these patients were males between the ages of 31 and 50, with about half being of Asian descent. In addition, 64 percent were from the mid-Atlantic or Pacific regions of the United States. The study was based on Internet interviews, supplemented by telephone interviews, conducted between September and November 2006.

Among the findings:

  • 36 percent of respondents mistakenly thought the virus could be spread through sharing utensils.
  • 80 percent were aware of the long-term consequences of the hepatitis B virus.
  • Half of the respondents erroneously believed a cure existed for the chronic virus, though just more than 60 percent had been in treatmen
    '"/>


Contact: Enrique Rivero
erivero@mednet.ucla.edu
310-794-2273
University of California - Los Angeles
24-May-2007


Page: 1 2

Related medicine news :

1. Hepatitis C negatively impacts HIV
2. Hepatitis C increases risk of non-Hodgkin lymphoma
3. HIV/Hepatitis information service through the Internet
4. Liver transplants can be successful in HIV patients with Hepatitis B
5. NDRI researchers evaluate prison Hepatitis program
6. Scientists call for Hepatitis treatment of young injection drug users
7. Hepatitis C recurs rapidly after liver transplant
8. Preventive treatment helps avoid Hepatitis B relapse during chemotherapy
9. Patients with Hepatitis C using more healthcare resources
10. Interferon with ribavirin is safe and effective for children with chronic Hepatitis C
11. Hepatitis C drug proves cost-effective in helping patients with treatment-induced anemia

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/19/2017)... ... September 19, 2017 , ... ... Safety for the President’s Malaria Initiative (PMI) Africa Indoor Residual Spraying (AIRS) ... Action Award. , The Innovation to Action Award, a USAID Catalyst Award, ...
(Date:9/19/2017)... Hill, CT (PRWEB) , ... September 19, 2017 ... ... support, today announced the winners of the Entrepreneur Innovation Awards (EIA), held this ... all of whom are Connecticut-based companies and entrepreneurs, presented their innovative project ideas ...
(Date:9/19/2017)... ... September 19, 2017 , ... The American Board of ... watch for the discomforts and hidden dangers of foot fungus, particularly in the ... at risk for developing fungal infections on the feet or toenails, the Board ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... Mirixa Corporation recently unveiled the MirixaPro 6.0 platform. As the industry’s leading ... management services are delivered. Based on industry research and market feedback, the ...
(Date:9/19/2017)... Philadelphia, PA (PRWEB) , ... September 19, 2017 ... ... high-quality orthopedic dog beds, has been officially recognized for its September 2016 donation ... , The company recently received three awards and honors for its contribution ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... 6, 2017  Robert G. Szewc, M.D., is recognized ... in recognition of his contributions to the Medical field.  ... Nephrologist at the practice of Kidney and Hypertension Specialists, ... and hypertension solutions. He has worked in this position ... experience, as well as expertise in kidneys, hypertension, chronic ...
(Date:9/6/2017)... Del. , Sept. 6, 2017 NeuroRx, a ... Acute Suicidal Ideation and Behavior (ASIB), has been granted Fast ... its sequential therapy of NRX-100 (ketamine HCl) followed by NRX-101 ... in a pivotal trial of this sequential therapy targeting patients ... depression. 1 ...
(Date:9/5/2017)... has announced another milestone in their continued growth and success of the company.  ... of customer engagements regionally.  ... is located at 318 West Adams Street, Suite 1528, Chicago, IL ... Xyntek's recently opened Midwest office will ... In addition to ...
Breaking Medicine Technology:
Cached News: